Three Dimensional Printing of Bio-Ink Compositions
US-2017218228-A1 · Aug 3, 2017 · US
US10118005B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10118005-B2 |
| Application number | US-201314019714-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 6, 2013 |
| Priority date | Mar 7, 2011 |
| Publication date | Nov 6, 2018 |
| Grant date | Nov 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein is a delivery system, including: (a) an optical sensor configured to detect data to create a map of a patient bodily surface; and (b) a dispenser operatively associated with the optical sensor and configured to deliver compositions (optionally including cells) to the patient bodily surface based upon the data or map. Methods of forming a tissue on a patient bodily surface of a patient in need thereof are also provided, as are methods, systems and computer program products useful for processing patient bodily surface data.
Opening claim text (preview).
That which is claimed is: 1. A method of dispensing a composition onto a bodily surface of a patient in need thereof, comprising: (a) detecting said bodily surface with an optical detector to obtain three-dimensional coordinates thereof, wherein said optical detector further comprises a depth detector to account for movement of the patient; (b) processing the three-dimensional coordinates by: (i) interpreting the coordinates to form a model of the bodily surface; (ii) transforming the model into a negative mold of the bodily surface, which mold is split into a plurality of Z-axis layers; and (iii) overlaying each of said Z-axis layers in the negative mold with a series of lines which represent coverage of the bodily surface, wherein said lines provide a path for a dispenser; and (c) dispensing the composition onto said bodily surface of said patient with said dispenser based upon said coordinates, wherein the dispensing step is carried out by: (i) mixing fibroblast cells with a hydrogel to form a composition comprising fibroblast cells; (ii) dispensing the composition comprising fibroblast cells onto the bodily surface; (iii) crosslinking the composition comprising fibroblast cells to form a gel layer; and (iv) dispensing a composition comprising keratinocytes over the gel layer. 2. The method of claim 1 , wherein the dispensing step (ii) is carried out not more than five minutes after said mixing step (i). 3. The method of claim 1 , wherein said hydrogel comprises fibrinogen. 4. The method of claim 1 , wherein said hydrogel comprises collagen. 5. The method of claim 1 , wherein the composition comprising keratinocytes comprises a hydrogel. 6. The method of claim 5 , wherein the keratinocytes is mixed in the hydrogel not more than five minutes prior to the dispensing step (iv). 7. The method of claim 1 , wherein said fibroblast cells are delivered at a concentration of about 50,000 to 500,000 cells per cm 2 . 8. The method of claim 1 , wherein said keratinocytes are delivered at a concentration of about 50,000 to 500,000 cells per cm 2 . 9. The method of claim 1 , wherein said fibroblast cells and said keratinocytes are autologous with respect to said patient. 10. The method of claim 9 , wherein said fibroblast cells are produced by obtaining cells from said patient and culturing said cells to form a cell culture. 11. The method of claim 9 , wherein said keratinocytes are produced by obtaining cells from said patient and culturing said cells to form a cell culture. 12. The method of claim 1 , wherein said optical detector is a hand-held scanner. 13. The method of claim 1 , wherein the dispensing step (ii) or the dispensing step (iv) is carried out in a time of from 5 to 30 minutes. 14. The method of claim 1 , wherein the dispensing step (ii) or the dispensing step (iv) is carried out by depositing drops of said composition along said path, wherein said drops have a volume of from 1 to 500 microliters. 15. The method of claim 14 , wherein said drops have a volume of from 50 to 250 microliters. 16. The method of claim 1 , wherein said composition comprises viable cells and wherein said dispensing step comprises forming a tissue. 17. The method of claim 16 , wherein said tissue is skin tissue. 18. The method of claim 1 , wherein said optical detector is a scanner. 19. The method of claim 1 , wherein the Z-axis layers correspond to one or more tissue layers. 20. The method of claim 1 , wherein said depth detector comprises a range camera that collects three-dimensional scene information from a continuously-projected light. 21. The method of claim 20 , wherein said continuously-projected light is an infrared structured light. 22. The method of claim 1 , wherein the three-dimensional coordinates are updated in real time during said dispensing.
Non-portable devices, e.g. spraying booths · CPC title
Supports for surgical instruments, e.g. articulated arms · CPC title
Modelling of the patient, e.g. for ligaments or bones · CPC title
Fibrin; Fibrinogen · CPC title
Body surface scanning · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.